Christopher Hwang
Directeur Technique/Scientifique/R&D chez TRANSCENTA HOLDING LIMITED
Postes actifs de Christopher Hwang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Directeur Technique/Scientifique/R&D | 01/02/2019 | - |
Historique de carrière de Christopher Hwang
Anciens postes connus de Christopher Hwang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANOFI | Directeur/Membre du Conseil | 01/01/2005 | 01/09/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2005 | 01/02/2016 |
Formation de Christopher Hwang
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Chine | 2 |
| France | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| SANOFI | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Christopher Hwang
- Expérience
